Taiwan · Delayed Price · Currency is TWD Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 16.07 billion. The enterprise value is 14.02 billion.
| Market Cap | 16.07B |
| Enterprise Value | 14.02B |
Important Dates
The next estimated earnings date is Wednesday, May 20, 2026.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has decreased by -5.52% in one year.
| Current Share Class | 148.14M |
| Shares Outstanding | 148.14M |
| Shares Change (YoY) | -5.52% |
| Shares Change (QoQ) | +16.46% |
| Owned by Insiders (%) | 11.71% |
| Owned by Institutions (%) | 18.31% |
| Float | 115.84M |
Valuation Ratios
The trailing PE ratio is 12.90.
| PE Ratio | 12.90 |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | 8.12 |
| P/OCF Ratio | 6.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.32, with an EV/FCF ratio of 7.09.
| EV / Earnings | 11.83 |
| EV / Sales | 1.36 |
| EV / EBITDA | 5.32 |
| EV / EBIT | 6.62 |
| EV / FCF | 7.09 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.60 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.10 |
| Interest Coverage | 440.22 |
Financial Efficiency
Return on equity (ROE) is 15.58% and return on invested capital (ROIC) is 21.33%.
| Return on Equity (ROE) | 15.58% |
| Return on Assets (ROA) | 8.64% |
| Return on Invested Capital (ROIC) | 21.33% |
| Return on Capital Employed (ROCE) | 17.41% |
| Weighted Average Cost of Capital (WACC) | 5.63% |
| Revenue Per Employee | 20.51M |
| Profits Per Employee | 2.37M |
| Employee Count | 501 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.35 |
Taxes
In the past 12 months, Grape King Bio has paid 428.60 million in taxes.
| Income Tax | 428.60M |
| Effective Tax Rate | 19.07% |
Stock Price Statistics
The stock price has decreased by -20.96% in the last 52 weeks. The beta is 0.26, so Grape King Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -20.96% |
| 50-Day Moving Average | 117.49 |
| 200-Day Moving Average | 124.37 |
| Relative Strength Index (RSI) | 17.47 |
| Average Volume (20 Days) | 240,607 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 10.28 billion and earned 1.19 billion in profits. Earnings per share was 8.41.
| Revenue | 10.28B |
| Gross Profit | 7.63B |
| Operating Income | 2.10B |
| Pretax Income | 2.25B |
| Net Income | 1.19B |
| EBITDA | 2.56B |
| EBIT | 2.10B |
| Earnings Per Share (EPS) | 8.41 |
Balance Sheet
The company has 4.09 billion in cash and 200.46 million in debt, with a net cash position of 3.89 billion or 26.27 per share.
| Cash & Cash Equivalents | 4.09B |
| Total Debt | 200.46M |
| Net Cash | 3.89B |
| Net Cash Per Share | 26.27 |
| Equity (Book Value) | 11.83B |
| Book Value Per Share | 57.18 |
| Working Capital | 2.02B |
Cash Flow
In the last 12 months, operating cash flow was 2.55 billion and capital expenditures -568.02 million, giving a free cash flow of 1.98 billion.
| Operating Cash Flow | 2.55B |
| Capital Expenditures | -568.02M |
| Depreciation & Amortization | 461.23M |
| Net Borrowing | -73.64M |
| Free Cash Flow | 1.98B |
| FCF Per Share | 13.36 |
Margins
Gross margin is 74.28%, with operating and profit margins of 20.44% and 11.53%.
| Gross Margin | 74.28% |
| Operating Margin | 20.44% |
| Pretax Margin | 21.87% |
| Profit Margin | 11.53% |
| EBITDA Margin | 24.93% |
| EBIT Margin | 20.44% |
| FCF Margin | 19.25% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 5.48%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 5.48% |
| Dividend Growth (YoY) | -13.04% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 79.98% |
| Buyback Yield | 5.52% |
| Shareholder Yield | 11.00% |
| Earnings Yield | 7.38% |
| FCF Yield | 12.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
| Last Split Date | Sep 15, 2005 |
| Split Type | Forward |
| Split Ratio | 1.0205 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |